Corvus Pharmaceuticals
CRVS | NASDAQ
$10.60
-$0.04 (-0.38%)
At close: Nov 16, 2026, 4:00 PM ET
$10.81
+$0.21 (+1.98%)
After-hours:
Nov 16, 2026, 7:50 PM ET
Corvus Pharmaceuticals Statistics
Key statistics explainedMarket Data
$980.37M
$778.06M
0.86
1.07M
92.49M
11.65%
76.79%
NASDAQ
US2210151005
Price Performance
11.3%
-28.9%
-13.2%
37.7%
19.0%
631.0%
195.3%
11.3%
20.9%
24.2%
-3.5%
Valuation
-14.32
N/A
0.09
-0.06
N/A
778.10
4.71
-20.45
-17.02
-20.78
N/A
-18.76
-12.40
-16.23
-7.0%
-4.9%
-5.9%
Financial Health
$202.31M
$632K
$202.95M
$223.88M
13.38
13.38
0.00
-0.01
-0.01
-74.65
0.00
35.46
2
Margins & Profitability
0.0%
0.0%
0.0%
0.0%
N/A
N/A
0.0%
-20.2%
Returns
-28.7%
-35.0%
-32.4%
-32.5%
-28.7%
Historical Growth (CAGR)
N/A
N/A
N/A
12.9%
5.2%
17.3%
-37.9%
-15.6%
3.0%
Analyst Forecasts
Buy
4
-4.0%
N/A
Mar 11, 2027
-$0.24
60.0%
N/A
N/A
Fair Value Estimates
N/A
N/A
N/A
N/A
$27.00
154.7%
Cash Flow
$-47.18M
$-47.94M
$-57.6M
-$0.52
-$0.51
0.0%
Income Statement
$0
$-55K
$-67.75M
$-62.75M
$-64.32M
-$0.74
N/A
$-1.74M
37
Add to Watchlist
Select watchlists to add or remove CRVS